Jorge Labrador-Gomez

32PUBLICATIONS
299CO-AUTHORS
Haematological tumoursImmunology not elsewhere classifiedMedical virologyNanomedicinePeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|May 07, 2026
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group.

|May 04, 2026
Impact of CYP and ABCB1 Polymorphisms on Bortezomib-Induced Adverse Events in Multiple Myeloma.

|Mar 27, 2026
Reply to: Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML.

Pau Montesinos, Jorge Labrador, Pilar Lloret-Madrid

|Mar 19, 2026
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.

Jon Salmanton-García, Francesco Marchesi, Erica Mackenzie

|Aug 30, 2025
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.

Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull

|Jul 30, 2025
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study.

Noelia Pérez-Gómez, Antonio Sanz-Solas, Beatriz Cuevas

Pageof 6

Frequent Collaborators

8 joint publications

David Martínez-Cuadrón

8 joint publications

Jon Salmanton-García

7 joint publications

Andreas Glenthøj

7 joint publications

Oliver A Cornely